Webinar: Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing

© poba/Getty Images
© poba/Getty Images

Life Sciences industry is undergoing a fundamental shift, driven by new technologies, e.g. personalized medicines, digital health, continuous processes, as well as the drive to lower healthcare cost and changes in re-imbursement to a value-based pricing model.

Digitalization is instrumental in facilitating a successful transformation to a flexible, agile and cost-effective pharma manufacturing. Virtual twins can significantly improve the quality and efficiency of projects in engineering and commissioning as well as help improve performance during operations and maintenance.

 

Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing
March 26, 2020 | 10.00 a.m. (CET)

           

Join this webinar to:

  • Understand the current industry challenges and the limitations of current approaches
  • Discover how using a virtual twin approach can bring value
  • Learn from practical experiences

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.